Related Experiment Video
Updated: Jul 3, 2026

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
Duhuo Jisheng Decoction Mitigates Intervertebral Disc Degeneration via Metabolic Reprogramming and TGF-β/Smad-Driven
Chao Song1,2, Xiaofei Wu1, Chaoqi Chen1
1Department of Orthopedics, The Second Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, China.
Duhuo Jisheng Decoction (DHJSD) treats intervertebral disc degeneration (IVDD) by reprogramming metabolism, regulating the TGF-β pathway, and remodeling autophagy and mitochondria. This multi-omics study reveals DHJSD
Area of Science:
- Integrative Medicine and Pharmacology
- Molecular Biology and Biochemistry
- Systems Biology
Background:
- Intervertebral disc degeneration (IVDD) is a complex condition with unclear therapeutic mechanisms.
- Traditional Chinese Medicine, like Duhuo Jisheng Decoction (DHJSD), shows potential for IVDD treatment.
- The precise molecular pathways, including autophagy and fibrosis, targeted by DHJSD remain largely unelucidated.
Purpose of the Study:
- To systematically investigate the molecular mechanisms of Duhuo Jisheng Decoction (DHJSD) in treating intervertebral disc degeneration (IVDD).
- To explore DHJSD's effects on autophagy, fibrosis, and metabolic pathways.
- To validate findings using a multi-omics approach and functional studies.
Main Methods:
- Network pharmacology identified 254 potential active constituents and regulatory pathways of DHJSD.
- Metabolomics and UHPLC-Q-TOF/MS analyzed metabolic profiles and lipid homeostasis.
- In vitro and in vivo functional studies assessed effects on extracellular matrix, TGF-β signaling, autophagy markers, and animal models of IVDD.
Main Results:
- DHJSD attenuated extracellular matrix and fibrosis markers, reduced BMP2 expression, and decreased TGF-β/Smad2/3 phosphorylation.
- Metabolomic analysis revealed DHJSD reshapes lipid homeostasis via glycerophospholipid and sphingolipid metabolism, impacting TGF-β signaling.
- DHJSD modulated autophagy markers (LC3-II/LC3-I, BCL2, P62) and influenced glycolysis and oxidative phosphorylation, potentially via mitochondrial membrane changes.
Conclusions:
- DHJSD treats IVDD through a network involving metabolic reprogramming, TGF-β pathway regulation, and autophagy/mitochondrial remodeling.
- The findings highlight a multi-target therapeutic strategy for IVDD.
- This study demonstrates the value of integrating multi-omics approaches for understanding traditional medicine's mechanisms.
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology
Herniated Intervertebral Disc l: Introduction